Palisade Bio, Inc. (PALI) insider trading.
In Q3 2026, insiders at Palisade Bio, Inc. reported 13 non-derivative transactions on 6 Forms 3, 4 and 5: 6 open-market purchases worth $250K and 2 sales worth $410K.
- Transactions
- 13
- Purchases (P)
- 6
- Sales (S)
- 2
- Net shares, P minus S
- -73,678
- Insiders
- 3
- Last filed
- 2026-08-21
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Baltera Robert Jr. | Director | 6 | 6 | 0 |
| Finley John David | Director, Officer · CEO, CFO | 5 | 0 | 1 |
| Jones Mitchell Lawrence | Officer · Chief Medical Officer | 2 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-19 | Finley John David | G (A) | 88,400 | $0 | 88,451 | Form 4 |
| 2026-08-19 | Finley John David | G (D) | 88,400 | $0 | 129,288 | Form 4 |
| 2026-07-09 | Baltera Robert Jr. | P (A) | 25,000 | $1.96 | 461,904 | Form 4 |
| 2026-07-08 | Baltera Robert Jr. | P (A) | 20,000 | $1.99 | 436,904 | Form 4 |
| 2026-07-07 | Finley John David | M (A) | 133 | $0.7 | 217,688 | Form 4 |
| 2026-07-07 | Finley John David | S (D) | 146,798 | $2.07 | 217,555 | Form 4 |
| 2026-07-07 | Jones Mitchell Lawrence | S (D) | 51,880 | $2.05 | 94,009 | Form 4 |
| 2026-07-07 | Baltera Robert Jr. | P (A) | 30,000 | $2.03 | 416,904 | Form 4 |
| 2026-07-06 | Finley John David | M (A) | 335,167 | — | 364,353 | Form 4 |
| 2026-07-06 | Jones Mitchell Lawrence | M (A) | 131,167 | — | 145,889 | Form 4 |
| 2026-07-06 | Baltera Robert Jr. | P (A) | 20,000 | $2.05 | 386,904 | Form 4 |
| 2026-07-02 | Baltera Robert Jr. | P (A) | 10,000 | $1.98 | 366,904 | Form 4 |
| 2026-07-01 | Baltera Robert Jr. | P (A) | 20,000 | $1.98 | 356,904 | Form 4 |
Transaction codes in this quarter
Get PALI insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1357459&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · PALI company page · Palisade Bio, Inc. on SEC.gov
Questions
Are insiders buying or selling Palisade Bio, Inc. (PALI)?
In Q3 2026, insiders at Palisade Bio, Inc. reported 13 non-derivative transactions on 6 Forms 3, 4 and 5: 6 open-market purchases worth $250K and 2 sales worth $410K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Palisade Bio, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/pali.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.